Arbutus CEO William Collier To Retire Dec. 31, 2023
Portfolio Pulse from Benzinga Newsdesk
Arbutus Biopharma Corporation's CEO, William Collier, has announced his retirement effective December 31, 2023.
November 07, 2023 | 12:18 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Arbutus Biopharma Corporation's CEO, William Collier, is set to retire at the end of 2023. This could lead to potential changes in the company's leadership and strategic direction.
CEO retirements often lead to changes in a company's strategic direction, which can impact the company's stock. However, as the retirement is not immediate, the impact may not be immediate and will depend on the succession plan.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100